ÈÕ±¾avÉ«ÇéƬ

Dr. Bashir Al Hussein is a Urologic Oncologist and Assistant Professor of Urology at ÈÕ±¾avÉ«ÇéƬ. He received his Medical Degree from the University of Jordan School of Medicine in Amman, Jordan, his hometown. He completed his Urology residency at NewYork-Presbyterian /ÈÕ±¾avÉ«ÇéƬ Medical Center, followed by a Society of Urologic Oncology fellowship at Vanderbilt University Medical Center. Additionally, he earned a Master of Public Health, with a concentration in Epidemiology, from Vanderbilt University School of Medicine.

Dr. Al Hussein's research interests include applying epidemiological methods to improve care quality for cancer patients, focusing on decision-making, survivorship, and disparities stemming from social determinants of health. His work has led to publications in journals such as the Journal of the American Medical Association (JAMA), the New England Journal of Medicine, and JAMA Internal Medicine. He also is a recipient of the American Urological Association Research Scholar Award.

In his clinical practice, Dr. Al Hussein is committed to providing patient-centered care, leveraging both robotic and traditional open surgical approaches to effectively manage genitourinary cancers.

News

Most Men With Low-Risk Prostate Cancers Now Forgo Immediate Surgery

Decade-Long Study Offers Guidance on Treatments for Prostate Cancer

Insights into adverse effects may help guide prostate cancer treatment decision-making

Comparing Side Effects of Prostate Cancer Treatments

More U.S. Prostate Cancer Patients Choosing Active Surveillance

More Men Choose Active Surveillance for Prostate Cancer

More men with prostate cancer opting for active surveillance

10-year study evaluates prostate cancer treatments, side effects

Understanding Functional Outcomes in Prostate Cancer

Treatment Adverse Events Vary With Favorable, Unfavorable Prognosis in Prostate Cancer